Jim Simons Champions Oncology, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 124,691 shares of CSBR stock, worth $615,973. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,691

Previous 124,791 0.08%

Holding current value

$615,973

Previous $701,000 12.84%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.9 - $6.91 $490 - $691	-100 Reduced 0.08%	124,691 $611,000
Q4 2023 Feb 13, 2024	SELL	$4.56 - $6.59 $4,560 - $6,590	-1,000 Reduced 0.79%	124,791 $701,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $7.32 $4,680 - $6,588	900 Added 0.72%	125,791 $781,000
Q2 2023 Aug 11, 2023	SELL	$4.11 - $6.81 $6,576 - $10,896	-1,600 Reduced 1.26%	124,891 $797,000
Q1 2023 May 12, 2023	SELL	$4.0 - $4.67 $29,600 - $34,558	-7,400 Reduced 5.53%	126,491 $508,000

Q4 2022 Feb 13, 2023	SELL	$3.75 - $7.1 $33,967 - $64,311	-9,058 Reduced 6.34%	133,891 $604,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.47 $154,272 - $202,629	-21,397 Reduced 13.02%	142,949 $1.07 Million
Q2 2022 Aug 12, 2022	SELL	$6.81 - $8.31 $38,088 - $46,477	-5,593 Reduced 3.29%	164,346 $1.32 Million
Q1 2022 May 13, 2022	SELL	$7.26 - $8.53 $151,058 - $177,483	-20,807 Reduced 10.91%	169,939 $1.38 Million
Q4 2021 Feb 11, 2022	SELL	$7.76 - $10.23 $235,904 - $310,992	-30,400 Reduced 13.75%	190,746 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$9.11 - $10.96 $62,858 - $75,624	-6,900 Reduced 3.03%	221,146 $2.26 Million
Q2 2021 Aug 13, 2021	SELL	$8.45 - $11.72 $3,270 - $4,535	-387 Reduced 0.17%	228,046 $2.34 Million
Q1 2021 May 13, 2021	BUY	$10.61 - $13.75 $70,949 - $91,946	6,687 Added 3.02%	228,433 $2.58 Million
Q4 2020 Feb 10, 2021	SELL	$8.39 - $13.27 $153,369 - $242,575	-18,280 Reduced 7.62%	221,746 $2.39 Million
Q3 2020 Nov 13, 2020	BUY	$7.05 - $10.2 $190,914 - $276,216	27,080 Added 12.72%	240,026 $2.22 Million
Q2 2020 Aug 13, 2020	BUY	$6.65 - $9.84 $238,735 - $353,256	35,900 Added 20.28%	212,946 $2.04 Million
Q1 2020 May 14, 2020	SELL	$4.19 - $8.62 $43,157 - $88,785	-10,300 Reduced 5.5%	177,046 $1.31 Million
Q4 2019 Feb 13, 2020	BUY	$5.12 - $8.33 $11,776 - $19,159	2,300 Added 1.24%	187,346 $1.56 Million
Q3 2019 Nov 13, 2019	BUY	$5.4 - $8.99 $23,760 - $39,556	4,400 Added 2.44%	185,046 $1.05 Million
Q2 2019 Aug 12, 2019	SELL	$7.51 - $10.12 $84,863 - $114,355	-11,300 Reduced 5.89%	180,646 $1.41 Million
Q1 2019 May 14, 2019	SELL	$7.89 - $12.23 $375,564 - $582,148	-47,600 Reduced 19.87%	191,946 $1.88 Million
Q4 2018 Feb 13, 2019	BUY	$7.29 - $15.27 $1.75 Million - $3.66 Million	239,546 New	239,546 $1.87 Million

Others Institutions Holding CSBR

# of Institutions

Shares Held

5.67M

Call Options Held

2.6K

Put Options Held

9.2K

View Full List

About CHAMPIONS ONCOLOGY, INC.

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $66.8M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

More about CSBR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account